Capital Advisors Ltd’s Ionis Pharmaceuticals IONS Stock Holding History

Capital Advisors Ltd’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13K	Hold	295	–	–	﹤0.01%	815
2026 Q2	$23K	Hold	295	–	–	﹤0.01%	659
2026 Q1	$22K	Hold	295	–	–	﹤0.01%	645
2025 Q4	$23K	Hold	295	–	–	﹤0.01%	623
2025 Q3	$19K	Hold	295	–	–	﹤0.01%	660
2025 Q2	$12K	Buy	+295	New	+$9.7K	﹤0.01%	744
2025 Q1	–	Sell	-179	Closed	-$6K	–	1455
2024 Q4	$6K	Buy	+179	New	+$6.69K	﹤0.01%	909
2024 Q2	–	Sell	-7	Closed	–	–	1510
2024 Q1	$0	Buy	+7	New	+$334	﹤0.01%	1453
2023 Q1	–	Sell	-63	Closed	-$2K	–	1368
2022 Q4	$2K	Buy	63 +59	+1,475%	+$2.48K	﹤0.01%	863
2022 Q3	$0	Buy	+4	New	+$169	﹤0.01%	1353

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Capital Advisors Ltd's IONS Position: Q3 2026 in Review

Capital Advisors Ltd held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 295 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Capital Advisors Ltd first reported a position in IONS in Q3 2022 and has held it in 10 quarters since. The position peaked at $23K in Q2 2026. 227 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

Capital Advisors Ltd held 295 shares of Ionis Pharmaceuticals worth $13K as of Q3 2026.
Capital Advisors Ltd left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #815 holding.
Capital Advisors Ltd first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
Capital Advisors Ltd's Ionis Pharmaceuticals position peaked at $23K in Q2 2026.
227 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.